CCRA Regulatory Compliance and ICH-GCP 3

Question 1

ICH E6(R2) defines 'essential documents' as those that individually and collectively permit evaluation of the conduct of a trial and:

Accepted Answer

The quality of the data produced

Answer

The financial costs incurred

Answer

The publication timeline

Answer

The site selection criteria

Question 2

In the US, a sponsor must submit an IND application to the FDA before:

Accepted Answer

Both B and C

Answer

Publishing trial results

Answer

Shipping investigational drug to sites

Answer

Initiating a Phase I clinical trial in humans

Question 3

Which GCP principle states that the rights, safety, and well-being of trial subjects are the most important considerations?

Accepted Answer

Ethical principle of primacy of subject protection

Answer

Data integrity principle

Answer

Scientific validity principle

Answer

Principle of equipoise

Question 4

What is the primary purpose of a Form FDA 1572 (Statement of Investigator)?

Accepted Answer

To document the investigator's commitments and qualifications to conduct the trial per FDA regulations

Answer

To authorize IRB approval

Answer

To report adverse events to the sponsor

Answer

To request drug shipment from the manufacturer

Question 5

Which document type serves as the definitive guide for CRAs on how to perform site visits for a specific trial?

Accepted Answer

Monitoring Plan

Answer

Investigator Brochure

Answer

Clinical Study Report

Answer

Site Initiation Checklist

Question 6

When a protocol amendment requires IRB approval before implementation, who is responsible for ensuring the amendment is approved prior to implementation at the site?

Accepted Answer

The Sponsor

Answer

The CRO

Answer

The Principal Investigator

Answer

The IRB Chair